194 related articles for article (PubMed ID: 9869600)
1. The kappa agonist fedotozine relieves hypersensitivity to colonic distention in patients with irritable bowel syndrome.
Delvaux M; Louvel D; Lagier E; Scherrer B; Abitbol JL; Frexinos J
Gastroenterology; 1999 Jan; 116(1):38-45. PubMed ID: 9869600
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of peripheral kappa agonist fedotozine versus placebo in treatment of irritable bowel syndrome. A multicenter dose-response study.
Dapoigny M; Abitbol JL; Fraitag B
Dig Dis Sci; 1995 Oct; 40(10):2244-9. PubMed ID: 7587797
[TBL] [Abstract][Full Text] [Related]
3. Pharmacology and clinical experience with fedotozine.
Delvaux M
Expert Opin Investig Drugs; 2001 Jan; 10(1):97-110. PubMed ID: 11116283
[TBL] [Abstract][Full Text] [Related]
4. Effect of alosetron on responses to colonic distension in patients with irritable bowel syndrome.
Delvaux M; Louvel D; Mamet JP; Campos-Oriola R; Frexinos J
Aliment Pharmacol Ther; 1998 Sep; 12(9):849-55. PubMed ID: 9768527
[TBL] [Abstract][Full Text] [Related]
5. The kappa agonist fedotozine modulates colonic distention-induced inhibition of gastric motility and emptying in dogs.
Gué M; Junien JL; Buéno L
Gastroenterology; 1994 Nov; 107(5):1327-34. PubMed ID: 7926497
[TBL] [Abstract][Full Text] [Related]
6. Octreotide increases thresholds of colonic visceral perception in IBS patients without modifying muscle tone.
Bradette M; Delvaux M; Staumont G; Fioramonti J; Bueno L; Frexinos J
Dig Dis Sci; 1994 Jun; 39(6):1171-8. PubMed ID: 8200249
[TBL] [Abstract][Full Text] [Related]
7. Effect of asimadoline, a kappa opioid agonist, on pain induced by colonic distension in patients with irritable bowel syndrome.
Delvaux M; Beck A; Jacob J; Bouzamondo H; Weber FT; Frexinos J
Aliment Pharmacol Ther; 2004 Jul; 20(2):237-46. PubMed ID: 15233705
[TBL] [Abstract][Full Text] [Related]
8. Effect of the kappa agonist fedotozine on perception of gastric distension in healthy humans.
Coffin B; Bouhassira D; Chollet R; Fraitag B; De Meynard C; Geneve J; Lemann M; Willer JC; Jian R
Aliment Pharmacol Ther; 1996 Dec; 10(6):919-25. PubMed ID: 8971289
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of the peripheral kappa agonist fedotozine versus placebo in the treatment of functional dyspepsia.
Read NW; Abitbol JL; Bardhan KD; Whorwell PJ; Fraitag B
Gut; 1997 Nov; 41(5):664-8. PubMed ID: 9414975
[TBL] [Abstract][Full Text] [Related]
10. Oxytocin increases thresholds of colonic visceral perception in patients with irritable bowel syndrome.
Louvel D; Delvaux M; Felez A; Fioramonti J; Bueno L; Lazorthes Y; Frexinos J
Gut; 1996 Nov; 39(5):741-7. PubMed ID: 9014776
[TBL] [Abstract][Full Text] [Related]
11. Effect of fedotozine on human distal colon.
Adami M; Bertaccini G; Roncoroni L; Cobianchi F
Ital J Gastroenterol; 1996; 28(8):441-6. PubMed ID: 9032586
[TBL] [Abstract][Full Text] [Related]
12. Fedotozine blocks hypersensitive visceral pain in conscious rats: action at peripheral kappa-opioid receptors.
Langlois A; Diop L; Friese N; Pascaud X; Junien JL; Dahl SG; Rivière PJ
Eur J Pharmacol; 1997 Apr; 324(2-3):211-7. PubMed ID: 9145774
[TBL] [Abstract][Full Text] [Related]
13. Fedotozine, a kappa-opioid agonist, prevents spinal and supra-spinal Fos expression induced by a noxious visceral stimulus in the rat.
Bonaz B; Rivière PJ; Sinniger V; Pascaud X; Junien JL; Fournet J; Feuerstein C
Neurogastroenterol Motil; 2000 Apr; 12(2):135-47. PubMed ID: 10771495
[TBL] [Abstract][Full Text] [Related]
14. Exaggerated motility of the descending colon with repetitive distention of the sigmoid colon in patients with irritable bowel syndrome.
Fukudo S; Kanazawa M; Kano M; Sagami Y; Endo Y; Utsumi A; Nomura T; Hongo M
J Gastroenterol; 2002 Nov; 37 Suppl 14():145-50. PubMed ID: 12572883
[TBL] [Abstract][Full Text] [Related]
15. Effect of a kappa-opioid agonist, i.v. JNJ-38488502, on sensation of colonic distensions in healthy male volunteers.
Floyd BN; Camilleri M; Busciglio I; Sweetser S; Burton D; Wong GY; Kell S; Khanna S; Hwang S; Zinsmeister AR
Neurogastroenterol Motil; 2009 Mar; 21(3):281-90. PubMed ID: 18823290
[TBL] [Abstract][Full Text] [Related]
16. Kappa opioid receptor agonists differentially inhibit two classes of rat spinal neurons excited by colorectal distention.
Ness TJ
Gastroenterology; 1999 Aug; 117(2):388-94. PubMed ID: 10419920
[TBL] [Abstract][Full Text] [Related]
17. "Kapping" visceral pain in patients with irritable bowel syndrome: does it work?
Pasricha PJ
Gastroenterology; 1996 Aug; 111(2):531-3. PubMed ID: 8690223
[No Abstract] [Full Text] [Related]
18. Peripheral kappa-opioid receptors mediate the antinociceptive effect of fedotozine (correction of fetodozine) on the duodenal pain reflex inrat.
Diop L; Rivière PJ; Pascaud X; Junien JL
Eur J Pharmacol; 1994 Dec; 271(1):65-71. PubMed ID: 7698213
[TBL] [Abstract][Full Text] [Related]
19. Lipid-induced colonic hypersensitivity in irritable bowel syndrome: the role of 5-HT3 receptors.
Simrén M; Simms L; D'Souza D; Abrahamsson H; Björnsson ES
Aliment Pharmacol Ther; 2003 Jan; 17(2):279-87. PubMed ID: 12534414
[TBL] [Abstract][Full Text] [Related]
20. Evidence for the hypersensitivity of lumbar splanchnic afferents in irritable bowel syndrome.
Lembo T; Munakata J; Mertz H; Niazi N; Kodner A; Nikas V; Mayer EA
Gastroenterology; 1994 Dec; 107(6):1686-96. PubMed ID: 7958680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
